You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 4, April 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 43RD ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY, WASHINGTON, DC, MAY 19 TO 22, 1990-PAR T II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ubiquitin Hybrid Protein Gene Expression During Human Colon Cancer Progression

Ken-ichi Mafune, MD, PhD; Jau Min Wong, MD; Raymond J. Staniunas, MD; Michael L. Lu, PhD; T. S. Ravikumar, MD; Lan Bo Chen, PhD; Glenn D. Steele, Jr, MD, PhD

Arch Surg. 1991;126(4):462-466.


Abstract

• Ubiquitin is involved in cell-cycle control and DNA replication through a specific proteolytic pathway. Our previous studies demonstrated selected higher expression of a gene encoding ubiquitin-ribosomal protein S27a in poorly differentiated colon carcinoma cell lines. In this study, we evaluated this ubiquitin hybrid protein gene expression in surgical specimens of colon cancers. Northern blot analysis showed that ubiquitin hybrid protein messenger RNA was overexpressed in primary colon cancers compared with adjacent normal colon mucosae in 17 of 20 patients. Dot blot analysis of RNA of 27 tumor samples revealed significantly greater expression in higher Dukes' stage primary colon tumors and liver metastases. These data imply that protein translation machinery is highly activated during progression and metastasis of colon tumors, and that ubiquitin hybrid protein may be useful as a marker of biological aggressiveness.

(Arch Surg. 1991;126:462-466)



Author Affiliations

From the Department of Surgery, New England Deaconess Hospital (Drs Mafune, Staniunas, Ravikumar, and Steele) and the Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute (Drs Mafune, Wong, Lu, and Chen), Harvard Medical School, Boston, Mass. Drs Mafune and Ravikumar are currently with the Department of Surgery, Yale University School of Medicine, New Haven, Conn, and Dr Wong is with the Department of Internal Medicine, National Taiwan University Hospital, Taipei.


Footnotes

Accepted for publication December 30, 1990.

Read before the 43rd Annual Cancer Symposium of the Society of Surgical Oncology, Washington, DC, May 21, 1990.

Reprint requests to Department of Surgery, New England Deaconess Hospital, 110 Francis St 3A, Boston, MA 02215 (Dr Steele).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Expression of Ornithine Decarboxylase Messenger RNA in Human Esophageal Carcinoma
Mafune et al.
Clin. Cancer Res. 1999;5:4073-4078.
ABSTRACT | FULL TEXT  

Yeast Proteins Related to the p40/Laminin Receptor Precursor Are Required for 20S Ribosomal RNA Processing and the Maturation of 40S Ribosomal Subunits
Ford et al.
Cancer Res. 1999;59:704-710.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.